NCT05080231View on ClinicalTrials.gov

COVID-19 Immunity Assessment

CompletedOBSERVATIONAL
Enrollment

662

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
COVID-19
Trial Locations (1)

90220

DxTerity Diagnostics Inc., Compton

Sponsors
All Listed Sponsors
lead

DxTerity Diagnostics

INDUSTRY

NCT05080231 - COVID-19 Immunity Assessment | Biotech Hunter | Biotech Hunter